Direct megavoltage photon calibration service in Australia.

The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) maintains the Australian primary standard of absorbed dose. Until recently, the standard was used to calibrate ionisation chambers only in (60)Co gamma rays. These chambers are then used by radiotherapy clinics to determine linac output, using a correction factor (k Q) to take into account the different spectra of (60)Co and the linac. Over the period 2010-2013, ARPANSA adapted the primary standard to work in megavoltage linac beams, and has developed a calibration service at three photon beams (6, 10 and 18 MV) from an Elekta Synergy linac. We describe the details of the new calibration service, the method validation and the use of the new calibration factors with the International Atomic Energy Agency's TRS-398 dosimetry Code of Practice. The expected changes in absorbed dose measurements in the clinic when shifting from (60)Co to the direct calibration are determined. For a Farmer chamber (model 2571), the measured chamber calibration coefficient is expected to be reduced by 0.4, 1.0 and 1.1 % respectively for these three beams when compared to the factor derived from (60)Co. These results are in overall agreement with international absorbed dose standards and calculations by Muir and Rogers in 2010 of k Q factors using Monte Carlo techniques. The reasons for and against moving to the new service are discussed in the light of the requirements of clinical dosimetry.

Direct MC conversion of absorbed dose to graphite to absorbed dose to water for 60Co radiation.

The ARPANSA calibration service for (60)Co gamma rays is based on a primary standard graphite calorimeter that measures absorbed dose to graphite. Measurements with the calorimeter are converted to the absorbed dose to water using the calculation of the ratio of the absorbed dose in the calorimeter to the absorbed dose in a water phantom. ARPANSA has recently changed the basis of this calculation from a photon fluence scaling method to a direct Monte Carlo (MC) calculation. The MC conversion uses an EGSnrc model of the cobalt source that has been validated against water tank and graphite phantom measurements, a step that is required to quantify uncertainties in the underlying interaction coefficients in the MC code. A comparison with the Bureau International des Poids et Mesures (BIPM) as part of the key comparison BIPM.RI(I)-K4 showed an agreement of 0.9973 (53).

The Australian radiation protection and nuclear safety agency megavoltage photon thermoluminescence dosimetry postal audit service 2007-2010.

The Australian radiation protection and nuclear safety agency (ARPANSA) has continuously provided a level 1 mailed thermoluminescence dosimetry audit service for megavoltage photons since 2007. The purpose of the audit is to provide an independent verification of the reference dose output of a radiotherapy linear accelerator in a clinical environment. Photon beam quality measurements can also be made as part of the audit in addition to the output measurements. The results of all audits performed between 2007 and 2010 are presented. The average of all reference beam output measurements calculated as a clinically stated dose divided by an ARPANSA measured dose is 0.9993. The results of all beam quality measurements calculated as a clinically stated quality divided by an ARPANSA measured quality is 1.0087. Since 2011 the provision of all auditing services has been transferred from the Ionizing Radiation Standards section to the Australian Clinical Dosimetry Service (ACDS) which is currently housed within ARPANSA.

Enhanced epidermal dose caused by localized electron contamination from lead cutouts used in kilovoltage radiotherapy.

PURPOSE: To investigate and quantify electron contamination from the lead cutouts used in kilovoltage x-ray radiotherapy. METHODS: The lead cutouts were modeled with the Monte Carlo EGSnrc user codes DOSXYZnrc and DOSRZnrc for x-ray beams ranging from 50 to 300 kVp. The results from the model were confirmed with Gafchromic film measurements. The model and measurements investigated the dose distribution with and without gladwrap shielding under the lead, and dose distributions with round, square, and serrated edge cutouts. RESULTS: Large dose enhancement near the edges of the lead was observed due to electron contamination. At the epidermal/dermal border, there is double the dose at the edge of the lead compared to the central dose due to electron contamination for a 150 kVp beam and three times the dose for a 300 kVp beam. gladwrapTM shielding effectively removes the contaminant dose enhancement using ten and four layers for 300 and 150 kVp beams, respectively. CONCLUSIONS: The contaminant dose enhancement is undesirable as it could cause unnecessary erythema and hyperpigmentation at the border of the treated and untreated skin and lead to a poorer cosmetic outcome. The contamination is easily removed by gladwrap shielding placed under or around the lead cutout.

A comparison of Australian and Canadian calibration coefficients for air kerma and absorbed dose to water for 60Co gamma radiation.

Australian and Canadian calibration coefficients for air kerma and absorbed dose to water for 60Co gamma radiation have been compared using transfer standard ionization chambers of types NE 2561 and NE 2611A. Whilst the primary standards of air kerma are similar, both being thick-walled graphite cavity chambers but employing different methods to evaluate the Awall correction, the primary standards of absorbed dose to water are quite different. The Australian standard is based on measurements made with a graphite calorimeter, whereas the Canadian standard uses a sealed water calorimeter. The comparison result, expressed as a ratio of calibration coefficients R=N(ARPANSA)/N(NRC), is 1.0006 with a combined standard uncertainty of 0.35% for the air kerma standards and 1.0052 with a combined standard uncertainty of 0.47% for the absorbed dose to water standards. This demonstrates the agreement of the Australian and Canadian radiation dosimetry standards. The results are also consistent with independent comparisons of each laboratory with the BIPM reference standards. A 'trilateral' analysis confirms the present determination of the relationship between the standards, within the 0.09% random component of the combined standard uncertainty for the three comparisons.

Shift in absorbed dose for megavoltage photons when changing to TRS-398 in Australia.

Australian primary standards of air kerma and absorbed dose are realized in 60Co gamma rays. To calibrate the megavoltage photon beams from linear accelerators, radiotherapy centres have their ionization chamber calibrated in a 60Co beam and then use a protocol to transfer this calibration to the higher energy. The radiotherapy community is in the process of changing from the ACPSEM Protocol (Second Edition 1998) based on an air kerma calibration to the IAEA's TRS-398 Code of Practice, based on an absorbed dose to water calibration. To evaluate the shift in absorbed dose resulting from the new protocol, the absorbed dose should be determined using both protocols and compared. We present a formula for this shift which can be used to check the result. To use this formula the centre needs to measure a displacement correction and know the ratio of the air kerma to absorbed dose to water calibration factors at 60Co. We calculate the change they should expect by using the average ratio of the air kerma and absorbed dose to water calibration factors for NE2571 and NE2561 chambers, based on Australian standards, and by estimating the displacement correction from published depth dose data. We find the absorbed dose in a megavoltage photon beam to increase by between 0.1 and 0.6% for NE2571 chambers and between 0.7 and 1.1% for NE2561 chambers, for beams up to 35 MV. The dose measured using TRS-398 is always higher.

A temporal method of avoiding the Cerenkov radiation generated in organic scintillator dosimeters by pulsed mega-voltage electron and photon beams.

The output signal of an organic scintillator probe consists of a scintillation signal and Cerenkov and fluorescence radiation (CFR) signal when the probe is exposed to a mega-voltage photon or electron beam. The CFR signal is usually unwanted because it comes from both the scintillator and light guide and so it is not proportional to the absorbed dose in the scintillator. A new organic scintillator detector system has been constructed for absorbed dose measurement in pulsed mega-voltage electron and photon beams that are commonly used in radiotherapy treatment, eliminating most of the CFR signal. The new detector system uses a long decay constant BC-444G (Bicron, Newbury, OH, USA) scintillator which gives a signal that can be time resolved from the prompt CFR signal so that the measured contribution of prompt signal is negligible. The response of the new scintillator detector system was compared with the measurements from a plastic scintillator detector that were corrected for the signal contribution from the CFR, and to appropriately corrected ion chamber measurements showing agreement in the 16 MeV electron beam used.

The relative response of NE2561 and NE2611A ionization chambers in megavoltage x-ray beams.

The relative energy response of NE2561 and NE261 IA ionization chambers to megavoltage photon beams from the ARPANSA linac indicates significant differences between these two types of chamber. In 16 MV beams of TPR20(10) 0.779, differences of about 2% are observed. The results are expressed as ratios KQ of the beam quality correction factors kQ, where the kQ factor for each type of chamber is the ratio of the absorbed dose to water calibration factor ND, at the x-ray quality Q to that at 60Co. These results have implications for the use of generic kQ factors in dosimetry protocols and suggest that NE2561 and NE2611A ionization chambers cannot be assumed to be identical.

Water equivalence of plastic organic scintillators in megavoltage radiotherapy bremsstrahlung beams.

Plastic organic scintillators are often considered 'water equivalent' in megavoltage photon beams as they have similar atomic composition and density to water. Two plastic scintillators are evaluated for their 'water equivalence', using the Burlin cavity theory, in the photon energy range of 200 keV to 20 MeV. The Burlin theory predicts that the two investigated scintillator materials are likely to be 'water equivalent' in the energy range investigated. The prediction of the Burlin theory for one of these scintillators has been confirmed by absorbed dose measurements in bremsstrahlung beams between 13 and 19 MeV.

Dealing with Cerenkov radiation generated in organic scintillator dosimeters by bremsstrahlung beams.

An organic scintillator detector system has been developed for radiotherapy bremsstrahlung dosimetry. The scintillators are connected to photodiodes by light pipes as the photodiodes must be removed and shielded from the incident radiation. The photodiodes see visible and near-visible light emissions from the scintillator as well as Cerenkov and fluorescence radiation that has been generated and trapped in the scintillator and light pipe. The Cerenkov and fluorescence radiation limits the accuracy of the dosimeter. This work examines a range of methods for diminishing the signal contribution of Cerenkov and fluorescence radiation while optimizing the scintillator signal. Three methods of achieving these goals have been used. They are: reflective coatings on the scintillator, long-wavelength-emitting scintillators used in conjunction with the photodiode, and absorptive filters placed between the light guide and photodiode. The contribution of the Cerenkov radiation to the light seen by the photodiode has been modelled and the model predictions have been tested using bremsstrahlung beams of peak energy between 13 and 20 MV, showing agreement with measurement.

Experimental determination of the effective point of measurement of a parallel-plate ionisation chamber.

The effective point of measurement (EPM) of a Kemp-Barber parallel plate ionisation chamber exposed to cobalt-60 has been determined experimentally. The variation of the EPM as a function of plate separation and the build-up cap thickness has also been studied. In general, for a constant size of build-up cap, the EPM moves downstream from the inner front wall towards the back wall of the chamber as the plate separation decreases. For parallel plate chambers, conventional theoretical analyses suggest that the EPM is the inner front wall and that it shifts towards the geometric centre of the chamber as the plate separation increases. The experimentally determined variation of the EPM, which appears to contradict these conclusions, suggests that the distribution of ionisation within a parallel plate chamber is not adequately accounted for in present theoretical descriptions. Such considerations may also affect other experimental determinations of the EPM for cylindrical chambers, as many are based on a comparison using parallel plate ionisation chambers with an assumed EPM on the inner front wall.